Sarcopenia, Frailty and Risk Prediction in Geriatric Patients

episode

JAMA Clinical Reviews not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

By Order of the Faithfuls: Celebs? Don’t Need Them! (The Traitors: New Blood Recap) 1h 0m · 22 Sep 2026 · Two Ts In A Pod with Teddi Mellencamp and Tamra Judge

NPR News: 09-21-2026 8PM EDT 4 min · 22 Sep 2026 · NPR News Now

Alistair Nicholson in the studio! - AFL Coaches Association Senior Coach of the Year award | AFLCA CEO (22.09.26) 11 min · 22 Sep 2026 · Whateley

The Leadership Portfolio with Luke Hodge | Whateley (22.09.26) 21 min · 22 Sep 2026 · Whateley

8PM ET 09/21/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded09 Feb 2017

Publisherjamaclinicalreviews.libsyn.com ↗

Handlerec:7722903

Show notes

As people age, loss of muscle mass is inevitable, resulting in sarcopenia. Muscle loss contributes to overall weakness, which causes frailty. Frailty, in turn, is the generalized susceptibility to disease and injury, all of which causes loss of autonomy. Because of the potential for progressive decline in physical function in very elderly patients, accurate tools are needed to predict mortality risk to individualize treatments intended to improve longevity such as chemotherapy, management of chronic diseases, and surgery. In this podcast, sarcopenia, frailty, and risk prediction are discussed in the context of major trials studying them being conducted in Europe.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in